Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)

NCT00535743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General

Interventions

DRUG: Sugammadex
DRUG: Placebo
DRUG: Esmeron®

Sponsor

Merck Sharp & Dohme LLC